机构：[1]Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.[2]National Clinical Research Center for Hematologic Diseases, Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Institute of Blood and Marrow Transplantation, Colla, Soochow, China.[3]The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, China.[4]The First Affiliated Hospital of Soochow University, suzhou, China.[5]The First Afliated Hospital, and College of Clinical Medicine of Henan University of Science and Technology, Luoyang, China.[6]The First Affiliated Hospital of Guangxi Medical University, Gui Yang, Chile.[7]Qilu Hospital, Shandong University, Jinan, China.[8]The Affiliated Cancer Hospital of Zhengzhou University and Henan Cancer Hospital, zhengzhou, China.河南省肿瘤医院[9]The Second Hospital of Hebei Medical University, Hebei Key Laboratory of Hematology, Shijiazhuang, China.[10]Department of Hematology, Nanfang Hospital, Southern Medical University, GUANGZHOU, China.[11]School of Medicine, Zhejiang University.[12]Peking University People's Hospital, Peking University Institute of Hematology, Beijing, China.[13]Changzhou Second HospiAffiliated tal of Nanjing Medical University, Changzhou, China.[14]Children's Hospital of Soochow University.[15]Yantai Yuhuangding Hospital, Yantai, China.[16]The Affiliated Hospital of Inner Mongolia Medical University, Hohhot, China.[17]West China Hospital, Sichuan University, Chengdu, China.四川大学华西医院[18]Chengdu second people's Hospital, Chenddu, China.[19]The First Affiliated Hospital of Soochow University, Suzhou, Alabama, China.[20]the First Affiliated Hospital of Soochow University, Suzhou, China.[21]Jiangsu Institute of Hematology, the First Affiliated Hospital of Soochow University, Suzhou, China.
This study was supported by grant from the National Key R&D Program of China
(2019YFA0111004, 2022YFC2502701), the National Natural Science Foundation of China
(82170158, 81970142, 82100175), the Translational Research Grant of NCRCH (2021WSB01,
2020WSB03, 2020WSB11, 2020WSB13), the Open Project of Jiangsu Biobank of Clinical
Resources (SBK202003001, SBK202003003).
第一作者机构：[1]Jiangsu Institute of Hematology, Key Laboratory of Thrombosis and Hemostasis of Ministry of Health, Institute of Blood and Marrow Transplantation, Collaborative Innovation Center of Hematology, the First Affiliated Hospital of Soochow University, Soochow University, Suzhou, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Zhang Zhibo,Yin Jia,Lian Guoli,et al.A multi-center retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML[J].BLOOD ADVANCES.2024,8(4):889-894.doi:10.1182/bloodadvances.2023012006.
APA：
Zhang Zhibo,Yin Jia,Lian Guoli,Bao Xiebing,Hu Meng...&Chen Suning.(2024).A multi-center retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML.BLOOD ADVANCES,8,(4)
MLA：
Zhang Zhibo,et al."A multi-center retrospective comparison between systemic mastocytosis with t(8;21) AML and KIT mutant t(8;21) AML".BLOOD ADVANCES 8..4(2024):889-894
医学